BioPharma Dive21m
Syndax secures FDA OK for new kind of leukemia drug
Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...
FiercePharma2h
Syndax ⁠scores FDA approval for Revuforj after it disappointed in another acute leukemia indication
The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...
Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
IQVIA reported annual sales for the twelve months ending September 2024 of $4.3 billion for the brand and generic market for this product. About Elite Pharmaceuticals, Inc.
interaksyon.philstar8h
‘Right of every Filipino’: Generic brand advocates for affordable healthcare
Healthcare products provider RHEA Generics is committed to promoting affordable healthcare by offering generic medications ...
STAT17h
Syndax wins U.S. approval for leukemia treatment
The Food and Drug Administration approved on Friday a new drug developed by Syndax Pharmaceuticals to treat patients with a ...
FDA approves Cobenfy for adults with schizophrenia
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
Health and Me on MSN3d
Men In India Are Consuming More Male Potency Drug, Know What It Does
As per the reports, the sale of Sildenafil, which is an active ingredient in Viagra and is used to treat erectile dysfunction ...